These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21428809)

  • 1. GABAergic drugs and Alzheimer's disease.
    Limon A; Reyes-Ruiz JM; Miledi R
    Future Med Chem; 2011 Feb; 3(2):149-53. PubMed ID: 21428809
    [No Abstract]   [Full Text] [Related]  

  • 2. Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease.
    Garcia-Alloza M; Tsang SW; Gil-Bea FJ; Francis PT; Lai MK; Marcos B; Chen CP; Ramirez MJ
    Neurobiol Aging; 2006 Aug; 27(8):1110-7. PubMed ID: 15996794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Welcome to 'GABAergic drugs'.
    Ramachandran PV; Shekhar A
    Future Med Chem; 2011 Feb; 3(2):139-40. PubMed ID: 21428806
    [No Abstract]   [Full Text] [Related]  

  • 4. GABA(A) receptors in aging and Alzheimer's disease.
    Rissman RA; De Blas AL; Armstrong DM
    J Neurochem; 2007 Nov; 103(4):1285-92. PubMed ID: 17714455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.
    Govindpani K; Calvo-Flores Guzmán B; Vinnakota C; Waldvogel HJ; Faull RL; Kwakowsky A
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28825683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential use of GABAergic drugs in the treatment of asthma.
    Lu WY
    Future Med Chem; 2011 Feb; 3(2):145-7. PubMed ID: 21428808
    [No Abstract]   [Full Text] [Related]  

  • 7. A postmortem study of amino acid neurotransmitters in Alzheimer's disease.
    Ellison DW; Beal MF; Mazurek MF; Bird ED; Martin JB
    Ann Neurol; 1986 Nov; 20(5):616-21. PubMed ID: 2878639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic application of cerebral metabolism enhancers to Alzheimer's disease and their limitations].
    Hasegawa K
    Nihon Rinsho; 1988 Jul; 46(7):1575-9. PubMed ID: 3221465
    [No Abstract]   [Full Text] [Related]  

  • 9. [Etiopathogenesis and treatment of Alzheimer's disease].
    Kanios K
    Wiad Lek; 1986 Jan; 39(2):101-5. PubMed ID: 3014757
    [No Abstract]   [Full Text] [Related]  

  • 10. The GABAergic system as a therapeutic target for Alzheimer's disease.
    Calvo-Flores Guzmán B; Vinnakota C; Govindpani K; Waldvogel HJ; Faull RLM; Kwakowsky A
    J Neurochem; 2018 Sep; 146(6):649-669. PubMed ID: 29645219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of GABA in pain syndrome pathogenes].
    Kukushkin LN; Igonkina SI
    Patol Fiziol Eksp Ter; 2014; (1):68-78. PubMed ID: 25051687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural stem cells, acetylcholine and Alzheimer's disease.
    Fullwood NJ
    Nat Chem Biol; 2007 Aug; 3(8):435. PubMed ID: 17637767
    [No Abstract]   [Full Text] [Related]  

  • 13. [Participation of central H-cholinoreceptors in preventing respiration damping upon activation of the GABA-ergic system of the brain].
    Sliuta AD; Tarakanov IA; Safonov VA
    Biull Eksp Biol Med; 1995 Jan; 119(1):17-20. PubMed ID: 7718794
    [No Abstract]   [Full Text] [Related]  

  • 14. GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia.
    Lanctôt KL; Herrmann N; Mazzotta P; Khan LR; Ingber N
    Can J Psychiatry; 2004 Jul; 49(7):439-53. PubMed ID: 15362248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitter replacement therapy in Alzheimer's disease.
    Mohr E; Mendis T; Rusk IN; Grimes JD
    J Psychiatry Neurosci; 1994 Jan; 19(1):17-23. PubMed ID: 7908537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA transporters as targets for new drugs.
    Sałat K; Kulig K
    Future Med Chem; 2011 Feb; 3(2):211-22. PubMed ID: 21428816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicinal chemistry of ρ GABAC receptors.
    Ng CK; Kim HL; Gavande N; Yamamoto I; Kumar RJ; Mewett KN; Johnston GA; Hanrahan JR; Chebib M
    Future Med Chem; 2011 Feb; 3(2):197-209. PubMed ID: 21428815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD147, a gamma-secretase associated protein is upregulated in Alzheimer's disease brain and its cellular trafficking is affected by presenilin-2.
    Nahalkova J; Volkmann I; Aoki M; Winblad B; Bogdanovic N; Tjernberg LO; Behbahani H
    Neurochem Int; 2010 Jan; 56(1):67-76. PubMed ID: 19751784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: treatments in discovery and development.
    Citron M
    Nat Neurosci; 2002 Nov; 5 Suppl():1055-7. PubMed ID: 12403985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease: biological diagnosis.
    Ebinger G; Herregodts P; Michotte Y; Vanderheyden P; Vauqelin G
    Acta Neurol Belg; 1989; 89(3-4):132-4. PubMed ID: 2516958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.